The desire to close PFO’s for stroke and migraine was as strong as ever and the physicians unanimously agreed that closing with suture is a significant benefit over the umbrella “device” implant closure
Fountain Valley, California (PRWEB) July 12, 2013
Prof. Dr. Anthony Nobles, CEO of NMT2 also presented the NobleStitch at an all day symposium during the congress. More than 30 cardiologists participated in the all day one on one training sessions. Prof. Dr. Nobles commented, “the response from the cardiology community was overwhelming. The desire to close PFO’s for stroke and migraine was as strong as ever and the physicians unanimously agreed that closing with suture is a significant benefit over the umbrella “device” implant closure”.
Dr. Michael Mullen presented on his experience with the NobleStitch including his recent successful cases performed at the University College Hospital in London. Dr. Mullen commented “the NobleStitch system is potentially the best solution developed to date for PFO closure, this is the only system that can achieve closure without leaving a device behind”.
Ben Brosch, President of Nobles Medical II said, “This is the 4th year of presenting the evolution of the NobleStitch and now that we have entered the market, we are excited for the overwhelming response we received at the CSI”.
About Patent Foramen Ovale (PFO)
A PFO is a tunnel that exists between the left and right atrium of the heart. The tunnel, which is part of the normal fetal anatomy, should close shortly after birth. In 27% of the population the tunnel never closes. This tunnel can then allow clots and other chemicals to pass from the right to the left side of the heart freely bypassing the filter of the lungs. These clots and chemicals can cause strokes and other conditions such as severe migraines.
About the NobleStitch EL System
Nobles Medical Technologies II's NobleStitch EL is a catheter based system that allows a physician to place a suture in the PFO tunnel in the heart through a percutaneous puncture in the leg, in many cases under a local anesthetic in a catheter lab rather than an operating room. This eliminates the need for open-heart surgery or placement of a large metallic implant in the heart. The NobleStitch is not a “device” or mechanical implant it only places a simple polypropylene suture in the heart. By closing the hole or PFO, the therapy will reduce or eliminate the shunting from the right to the left side of the heart allowing the lungs to filter the clots and other chemicals from making it to the brain, potentially halting strokes and severe migraines and enabling patients to live a higher-quality life.
About Nobles Medical Technologies II
Nobles Medical Technologies II is a global structural heart company devoted to improving life through the development of its products and technologies. Nobles Medical Technologies II is focused on suture based solutions for the septum.
Visit Nobles Medical Technologies II http://www.noblesmedicaltechnology.com